Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia ; volume:21 ; number:1 ; day:15 ; month:6 ; year:2023 ; pages:1-18 ; date:12.2023
Journal of translational medicine ; 21, Heft 1 (15.6.2023), 1-18, 12.2023
- Urheber
-
Kurnellas, Michael
Mitra, Ananya
Schwabe, Tina
Paul, Robert
Arrant, Andrew E.
Roberson, Erik D.
Ward, Michael
Yeh, Felix
Long, Hua
Rosenthal, Arnon
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-023-04251-y
- URN
-
urn:nbn:de:101:1-2023092113020934090048
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kurnellas, Michael
- Mitra, Ananya
- Schwabe, Tina
- Paul, Robert
- Arrant, Andrew E.
- Roberson, Erik D.
- Ward, Michael
- Yeh, Felix
- Long, Hua
- Rosenthal, Arnon
- SpringerLink (Online service)
Ähnliche Objekte (12)
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice
Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia
Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia
Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia
Swallowing in behavioral variant frontotemporal dementia
An update on genetic frontotemporal dementia
Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia
Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice
Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia
Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia
Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia
Swallowing in behavioral variant frontotemporal dementia
An update on genetic frontotemporal dementia
Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia
Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice
Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia
Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia
Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia
Swallowing in behavioral variant frontotemporal dementia
An update on genetic frontotemporal dementia
Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia